Jenn Adams is the CEO of August Bioservices, a private VC-backed contract development and manufacturing organization serving biopharmaceutical and biotech customers. Jenn relocated to Nashville in July, 2020 to lead and scale this company following its successful acquisition by Oak HC/FT, a Venture Capital firm based in Connecticut.
Jenn has been serving in healthcare leadership roles for over 30 years. She has extensive experience leading, transforming, and driving growth in both Fortune 500 public, and private equity-backed companies. Jenn has deep domain expertise within the outsourced pharmaceutical services sector. Prior to assuming the role of CEO at August Bio, Jenn served as Executive in Residence at Oak HC/FT, and before that she was SVP & President for the Clinical Product Solutions business at AmerisourceBergen.
Jenn spent her early career at Baxter Healthcare serving in many roles within several of Baxter’s businesses.
Jenn holds a Master’s of Business Administration (MBA) from the Kellogg School of Management, Northwestern University.